Psoriasis and Hyperpyrexia

Summary:

Hyperpyrexia is found among people with Psoriasis, especially for people who are male, 60+ old.

The study analyzes which people have Hyperpyrexia with Psoriasis. It is created by eHealthMe based on reports of 23 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,516 drugs and 1,671 conditions by eHealthMe. Check the latest studies of Psoriasis.

What is Hyperpyrexia?

Hyperpyrexia (extremely high fever) is found to be associated with 454 drugs and 523 conditions by eHealthMe. Check the latest studies of Hyperpyrexia.



On Nov, 27, 2025

23 people who have Psoriasis and Hyperpyrexia are studied.

Would you have Hyperpyrexia when you have Psoriasis?

Gender of people who have Psoriasis and experienced Hyperpyrexia *:

  • female: 39.13 %
  • male: 60.87 %

Age of people who have Psoriasis and experienced Hyperpyrexia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 9.09 %
  • 20-29: 4.55 %
  • 30-39: 9.09 %
  • 40-49: 9.09 %
  • 50-59: 31.82 %
  • 60+: 36.36 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 6 people, 26.09%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 8.70%
  3. High Blood Cholesterol: 1 person, 4.35%
  4. Cardiac Disorder: 1 person, 4.35%

Common drugs taken by these people *:

  1. Cosentyx: 10 people, 43.48%
  2. Candesartan Cilexetil: 5 people, 21.74%
  3. Amlodipine: 5 people, 21.74%
  4. Norvasc: 4 people, 17.39%
  5. Enbrel: 2 people, 8.70%
  6. Taltz: 1 person, 4.35%
  7. Stelara: 1 person, 4.35%
  8. Skyrizi: 1 person, 4.35%
  9. Sandimmune: 1 person, 4.35%
  10. Remicade: 1 person, 4.35%

Common symptoms for these people *:

  1. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 7 people, 30.43%
  2. Dermatitis Exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss): 5 people, 21.74%
  3. Fever: 3 people, 13.04%
  4. Dyspnea (difficult or laboured breathing): 3 people, 13.04%
  5. Pneumonia: 3 people, 13.04%
  6. Rashes (redness): 3 people, 13.04%
  7. Weight Decreased: 2 people, 8.70%
  8. Relapsing Fever (bacterial infection characterized by recurring episodes of fever, headache, muscle and joint aches, and nausea): 2 people, 8.70%
  9. Itching: 2 people, 8.70%
  10. Loss Of Consciousness: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperpyrexia?

Check whether Hyperpyrexia is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hyperpyrexia:

All the conditions that are associated with Hyperpyrexia:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperpyrexia and Psoriasis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: